CAS: 405169-16-6 - Dovitinib
Formula:C21H21FN6O
InChI:InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)
InChI key:InChIKey=PIQCTGMSNWUMAF-UHFFFAOYSA-N
SMILES:O=C1NC=2C=CC=C(F)C2C(N)=C1C3=NC4=CC=C(C=C4N3)N5CCN(C)CC5
- Synonyms:
- 2(1H)-Quinolinone, 4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-
- 2(1H)-Quinolinone, 4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-
- 4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one
- 4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone
- Gfki 258
- Tk-258
- Tki 258
- Dovitinib
2(1H)-Quinolinone,4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-
CAS:405169-16-6
Formula:
C21H21FN6O
Purity:
99%
Color and Shape:
Solid
Molecular weight:
392.4294
Ref: IN-DA0076Y3
1g | To inquire | ||
5mg | 52.00 € | ||
10mg | 68.00 € | ||
50mg | 182.00 € | ||
100mg | 206.00 € | ||
250mg | 463.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 7W-GP8558
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-D-121002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Ref: 4Z-D-121001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
Dovitinib
CAS:405169-16-6
Dovitinib is an orally active, multi-targeted tyrosine kinase (RTK) inhibitor with anti-tumor effects.Cost-effective and quality-assured.
Formula:
C21H21FN6O
Purity:
98% - 99.78%
Color and Shape:
Solid
Molecular weight:
392.43
Ref: TM-T6289
5mg | 46.00 € | ||
10mg | 69.00 € | ||
25mg | 123.00 € | ||
50mg | 199.00 € | ||
100mg | 321.00 € | ||
200mg | 479.00 € | ||
500mg | 766.00 € | ||
1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Dovitinib base
CAS:405169-16-6
Receptor tyrosine kinase inhibitor; anti-angiogenesis; anti-oncogenesis
Formula:
C21H21FN6O
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
392.43 g/mol
Ref: 3D-FD22602
1mg | 136.00 € | ||
5mg | 298.00 € | ||
25mg | 711.00 € | ||
50mg | 1,021.00 € | ||
100mg | 1,913.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025